Published in Vaccine Weekly, August 8th, 2007
The results of the trial showed that 95% of the patients had disease regression or their disease remained stable. Seven of 20 women (35%) had complete regression of their...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly